Clinical Significance of In Vitro Synergism Between Antibiotics in Gram-Negative Infections |
| |
| Authors: | J. Klastersky R. Cappel D. Daneau |
| |
| Affiliation: | Service de Médecine et Laboratoire d''Investigation Clinique (Section des Maladies Infectieuses), Institut Jules Bordet, Centre des Tumeurs de l''Université Libre de Bruxelles, Brussels, Belgium |
| |
| Abstract: | Cells of proflavine-sensitive and -resistant Escherichia coli strains were altered in different ways, and the proflavine binding of the changed material was studied. Spheroplasts prepared from sensitive and resistant cells bound similar amounts of proflavine at saturation, whether or not they were osmotically protected by 10% sucrose. Intact cells bound approximately the same amounts of proflavine as spheroplasts. On addition of glucose, osmotically protected resistant but not sensitive spheroplasts released proflavine; unprotected spheroplasts did not release bound proflavine. Thus, osmotically protected membranes are not required for proflavine binding (a passive process) but are required for proflavine release (an active process). The presence of sucrose reduced proflavine binding by resistant cells. Adding glucose to cells in 20% sucrose did not cause a release of residual proflavine, though glucose caused a release of proflavine from cells suspended in 0 or 10% sucrose. On treatment of heated cells or ruptured spheroplasts with nucleases and Pronase, practically all nucleic acids were removed. Proflavine-binding ability of such preparations fell by only 30 to 50%. Washing heated cells with ethanol did not reduce their proflavine-binding ability. There appear to be important binding sites in cells aside from nucleic acids. |
| |
| Keywords: | |
|
|
